Search - tctmd.com

Displaying 81 - 100 of 115

Sort: Relevancy | Date

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

Presentation EuroPCR 2018

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

Presenter: Mayra Guerrero

May 24, 2018

Presentation EuroPCR 2018

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Presenter: Simon Redwood

May 24, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

Presentation EuroPCR 2018

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Presenter: Francesco Bedogni

May 23, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

Presentation EuroPCR 2018

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Presenter: Hasan Jilaihawi

May 23, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

Presentation EuroPCR 2017

Neurological Complications After Transcatheter Aortic Valve Implantation

Presenter: Pieter Kappetein

May 18, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

Presentation EuroPCR 2017

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma, Martin W. Bergmann

May 18, 2017

Presentation EuroPCR 2017

1-year Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification

Presenter: Mayra Guerrero

May 17, 2017

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve The ARTE Randomized Clinical Trial

Presentation EuroPCR 2017

The ARTE Randomized Clinical Trial

Presenter: Josep Rodés-Cabau

May 17, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

Presentation EuroPCR 2017

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

Presenter: Ulrich Gerckens

May 17, 2017

Advertisement

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

30-day Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease with Severe Mitral Annular Calcification in the United States: Data from the STS/ACC/TVT Registry

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Pace Quickens for Mitral Device Innovation for Repair, Replacement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Neurological Complications After Transcatheter Aortic Valve Implantation

More Early Stroke With SAVR Than TAVR in SURTAVI

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

1-year Outcomes of Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification

The ARTE Randomized Clinical Trial

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Final five-year Clinical and Echocardiographic Results of Treatment for Severe Aortic Stenosis with a Self-Expanding Bioprosthesis from the ADVANCE Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content